Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence and predictive tools in non-muscle invasive bladder cancer: a narrative review of current insights and advances.

Translational andrology and urology·2026
Same author

Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making.

European urology oncology·2026
Same author

Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBC.

The French journal of urology·2026
Same author

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer Committee.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Jun 26, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K

Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 Signaling.

Adam M Farkas, Dina Youssef, Michelle A Tran

    Biorxiv : the Preprint Server for Biology
    |May 15, 2024
    PubMed
    Summary

    Natural killer (NK) cells are crucial for cancer surveillance but are dysfunctional in bladder tumors. Tumor microenvironment factors, not receptor expression, impair NK cells, highlighting SLAMF6 as a therapeutic target.

    More Related Videos

    3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
    09:24

    3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

    Published on: September 13, 2018

    9.0K
    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    12.5K

    Related Experiment Videos

    Last Updated: Jun 26, 2025

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    21.3K
    3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
    09:24

    3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

    Published on: September 13, 2018

    9.0K
    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    12.5K

    Area of Science:

    • Immunology
    • Cancer Biology

    Background:

    • Natural killer (NK) cells are vital innate immune cells for identifying and eliminating virally infected cells and tumors.
    • NK cell dysfunction within the tumor microenvironment (TME) contributes to cancer progression, but the underlying mechanisms remain unclear.

    Purpose of the Study:

    • To investigate the mechanisms of NK cell dysfunction in bladder cancer.
    • To identify factors within the TME that impair NK cell effector functions.
    • To explore SLAMF6 signaling as a potential therapeutic target.

    Main Methods:

    • Comparison of NK cell effector function from peripheral blood and tumor tissues of bladder cancer patients.
    • Analysis of inhibitory receptor expression on NK cells.
    • Assessment of the impact of TME-specific factors, including TGF-β and hypoxia, on NK cell function.
    • Investigation of SLAMF6 signaling pathway in NK cells.
    • Ex vivo culture of tumor-infiltrating NK cells under normoxic conditions and assessment of function in SLAMF6-deleted NK cells.

    Main Results:

    • NK cells from bladder tumors exhibited significantly impaired effector function compared to peripheral blood NK cells.
    • Over-expression of inhibitory receptors did not fully account for NK cell defects.
    • Tumor microenvironment factors, specifically TGF-β and hypoxia, directly suppressed NK cell function.
    • An oxygen-dependent reduction in SLAMF6 signaling was identified as a key mechanism for NK cell dysfunction.
    • Restoration of normoxic conditions ex vivo rescued NK cell function, while SLAMF6 deletion abolished function even under normoxia.

    Conclusions:

    • Tissue-specific factors in the tumor microenvironment critically dictate NK cell function in bladder cancer.
    • SLAMF6 signaling is essential for NK cell cytolytic activity and is suppressed by the tumor microenvironment.
    • Targeting SLAMF6 signaling presents a promising strategy for immuno-modulatory therapies to enhance NK cell function in bladder cancer.